Highlights LifeTech Scientific Corporation

Equities

1302

KYG548721177

Market Closed - Hong Kong S.E. Other stock markets 01:38:05 02/07/2024 pm IST			5-day change	1st Jan Change
1.42 ^HKD	+2.16%		0.00%	-39.57%

16/05	LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold	MT
15/05	LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold	16/05	MT
LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	15/05	CI
Lifetech Scientific Buys Shares For Employee Incentive Scheme	11/04	MT
Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits	04/04	MT
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue	28/03	MT
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
LifeTech Scientific Flags Significant Profit Drop in 2023	08/03	MT
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	08/03	CI
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter	09/11	MT
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue	30/23/30	MT
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA	21/23/21	CI
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of IbsÂ®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed	10/23/10	CI
LifeTech Scientific Corporation Announces Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	12/23/12	CI
LifeTech Scientific Logs 68.6% Drop in 2022 Profit	29/23/29	MT
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29	CI
Lifetech Scientific and Jenscare Scientific to Cooperate on Business Development	08/23/08	MT
LifeTech Scientific Corporation Enters Strategic Cooperation Agreement with Jenscare Scientific Co., Ltd	06/23/06	CI
LifeTech Scientific Corporation Announces Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed	13/22/13	CI
LifeTech Scientific’s Aortic Stent Graft Admitted into China's Special Approval Procedure	20/22/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights LifeTech Scientific Corporation

Equities

1302

KYG548721177

Highlights

Filters